The finding that NF-κB controls the expression of vascular endothelial growth factor (VEGF) thus contributing to tumor angiogenesis can give support to the possible involvement of NF-κB signaling in the mechanism of the effects of RBP4. The gene discussed is NFKB1; the disease is neoplasm.